Abstract
Left ventricular assist devices (LVADs) are increasingly used as a treatment option for advanced heart failure. Fungal infections present a serious concern given the high association with major adverse events including death in this group of patients. The objective of this review is to summarize the incidence, risk factors, method for diagnosis, complication rate, and outcomes in patients with VADs who develop fungal infections.
© 2013 Wiley Periodicals, Inc.
MeSH terms
-
Antifungal Agents / administration & dosage
-
Aspergillosis
-
Candidiasis
-
Fluconazole / administration & dosage
-
Heart Failure / therapy
-
Heart-Assist Devices / adverse effects*
-
Heart-Assist Devices / microbiology*
-
Humans
-
Incidence
-
Mycoses / diagnosis
-
Mycoses / epidemiology
-
Mycoses / etiology*
-
Mycoses / therapy
-
Pyrimidines / administration & dosage
-
Risk Factors
-
Time Factors
-
Triazoles / administration & dosage
-
Voriconazole
Substances
-
Antifungal Agents
-
Pyrimidines
-
Triazoles
-
Fluconazole
-
Voriconazole